First Patient Enrolled in Phase II Clinical Trial of Stem Cell Therapy for Traumatic Injuries
The first patient has enrolled in a Phase II clinical trial evaluating a stem cell therapy for the potential early treatment of traumatic injuries and their subsequent complications at The University of Texas Health Science Center at Houston (UTHealth). The MATRICS-1 (MultiStem® Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas …